APA (7th ed.) Citation

Yang, X., Chen, Y., Yang, J., Lei, J., Liu, T., Mai, Y., & Tang, X. (2026). Amikacin-eravacycline combination mediates the synergistic elimination of carbapenem-resistant pathogens via in vitro and in vivo metabolic reprogramming. PLoS Pathogens, 22(2), 1. https://doi.org/10.1371/journal.ppat.1013938

Chicago Style (17th ed.) Citation

Yang, Xiaoli, Yili Chen, Jinmei Yang, Jiaying Lei, Tinghua Liu, Yougang Mai, and Xikang Tang. "Amikacin-eravacycline Combination Mediates the Synergistic Elimination of Carbapenem-resistant Pathogens via in Vitro and in Vivo Metabolic Reprogramming." PLoS Pathogens 22, no. 2 (2026): 1. https://doi.org/10.1371/journal.ppat.1013938.

MLA (9th ed.) Citation

Yang, Xiaoli, et al. "Amikacin-eravacycline Combination Mediates the Synergistic Elimination of Carbapenem-resistant Pathogens via in Vitro and in Vivo Metabolic Reprogramming." PLoS Pathogens, vol. 22, no. 2, 2026, p. 1, https://doi.org/10.1371/journal.ppat.1013938.